-
1 Comment
China Meheco Group Co., Ltd is currently in a long term downtrend where the price is trading 14.8% below its 200 day moving average.
From a valuation standpoint, the stock is 95.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.4.
China Meheco Group Co., Ltd's total revenue rose by 25.0% to $11B since the same quarter in the previous year.
Its net income has increased by 64.4% to $461M since the same quarter in the previous year.
Finally, its free cash flow grew by 296.3% to $961M since the same quarter in the previous year.
Based on the above factors, China Meheco Group Co., Ltd gets an overall score of 4/5.
| Exchange | SHG |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE000000Q29 |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Market Cap | 15B |
|---|---|
| PE Ratio | 27.86 |
| Target Price | 30.47 |
| Beta | 0.18 |
| Dividend Yield | None |
China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally. The company exports and imports natural medicines, pharmaceutical chemicals, medical equipment, and health products; produces and distributes pharmaceutical and health care products; and operates retail chain pharmacies. Its products include bulk pharmaceutical chemicals antibiotic fermentation and chemical synthesis tablets, injections, capsules, etc.; antibiotics; medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, and diabetes; antiviral; anti-infectious agents; gastrointestinal drugs; non-steroidal anti-inflammatory drugs; anti-allergic agents; specialty botanicals; western medicine preparations; Chinese patent medicines and herbal pieces; medical equipment and supplies; biological products; chemical raw materials; and nutritional and healthcare products. The company also plants, processes, warehouses, and transports ginseng, licorice, ephedra, rhubarb, rheum officinale, astragalus membranaceus, scutellaria baicalensis, fennel, and other herbs. China Meheco Group Co., Ltd. was founded in 1984 and is based in Beijing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600056.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
